Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer
Advanced Science · 2024
DOI: 10.1002/advs.202400845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Junmei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, 215123, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mitochondria, Liposomes, Metformin. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Social Development of Jiangsu Province, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Complete remission of colorectal cancer (CRC) is still unachievable in the majority of patients by common fractionated radiotherapy, leaving risks of tumor metastasis and recurrence. Herein, clinical CRC samples demonstrated a difference in the phosphorylation of translation initiation factor eIF2α (p‐eIF2α) and the activating transcription factor 4 (ATF4), whose increased expression by initial X‐ray irradiation led to the resistance to subsequent radiotherapy. The underlying mechanism is studied in radio‐resistant CT26 cells, revealing that the incomplete mitochondrial outer membrane permeabilization (iMOMP) triggered by X‐ray irradiation is key for the elevated expression of p‐eIF2α and ATF4, and therefore radio‐resistance. This finding guided to discover that metformin and 2‐DG are synergistic in reversing radio resistance by inhibiting p‐eIF2α and ATF4. Liposomes loaded with metformin and 2‐DG (M/D‐Lipo) are thus prepared for enhancing fractionated radiotherapy of CRC, which achieved satisfactory therapeutic efficacy in both local and metastatic CRC tumors by reversing radio‐resistance and preventing T lymphocyte exhaustion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, 215123, China.
- Department of Oncology, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, 225300, China.
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medic…
ORCID-Profile: Kai Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Social Development of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Key Project of Basic Research of Suzhou
- Suzhou health youth backbone talent "national tutorial system" training project
- Interdisciplinary Basic Frontier Innovation Program of Suzhou Medical College of Soochow University
- Research project of Taizhou Clinical College of Nanjing Medical University
- Beijing Xisike Clinical Oncology Research Foundation
Zitieren
APA
Li, J., Wang, Y., Shen, W., Zhang, Z., Su, Z., Guo, X., Pei, P., Hu, L., Liu, T., Yang, K., & Guo, L. (2024). Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer. Advanced Science. https://doi.org/10.1002/advs.202400845
Vancouver
Li J, Wang Y, Shen W, Zhang Z, Su Z, Guo X, et al. Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer. Advanced Science. 2024. doi:10.1002/advs.202400845
BibTeX
@article{Li2024,
author = {Li, Junmei and Wang, Yuhong and Shen, Wenhao and Zhang, Ziyu and Su, Zhiyue and Guo, Xia and Pei, Pei and Hu, Lin and Liu, Teng and Yang, Kai and Guo, Lingchuan},
title = {Mitochondria‐Modulating Liposomes Reverse Radio‐Resistance for Colorectal Cancer},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202400845}
}
EUVIMED